Papillomavirus E2 polypeptide used for vaccination

Details for Australian Patent Application No. 2008209759 (hide)

Owner Transgene S.A.

Inventors Baudin, Martine; Silvestre, Nathalie; Balloul, Jean-Marc

Agent Davies Collison Cave

Pub. Number AU-A-2008209759

PCT Pub. Number WO2008/092854

Priority 07360004.1 30.01.07 EP; 07360018.1 15.05.07 EP

Filing date 29 January 2008

Wipo publication date 7 August 2008

International Classifications

C12N 15/86 (2006.01) Mutation or genetic engineering - Viral vectors

A61K 39/12 (2006.01) Medicinal preparations containing antigens or antibodies - Viral antigens

C07K 14/025 (2006.01) Peptides having more than 20 amino acids

C12N 7/04 (2006.01) Viruses, e.g. bacteriophages - Inactivation or attenuation

C12N 15/863 (2006.01) Mutation or genetic engineering - Poxviral vectors, e.g. vaccinia virus

Event Publications

6 August 2009 PCT application entered the National Phase

  PCT publication WO2008/092854 Priority application(s): WO2008/092854

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008209771-Transgenic plant event detection

2008209749-Piperidin-acetamide derivatives for the treatment of inflammatory or allergic diseases